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Chromosome fragmentation (C-Frag) is a newly identiﬁed MCD (mitotic cell death), distinct from apoptosis and MC (mitotic
catastrophe).AsdifferentmolecularmechanismscaninduceC-Frag,wehypothesizethatthegeneralmechanismofitsinduction
is a system response to cellular stress. A clear link between C-Frag and diverse system stresses generated from an array of
molecular mechanisms is shown. Centrosome ampliﬁcation, which is also linked to diverse mechanisms of stress, is shown to
occur in association with C-Frag. This led to a new model showing that diverse stresses induce common, MCD. Speciﬁcally,
different cellular stresses target the integral chromosomal machinery, leading to system instability and triggering of MCD by
C-Frag. This model of stress-induced cell death is also applicable to other types of cell death. The current study solves the
previously confusing relationship between the diverse molecular mechanisms of chromosome pulverization, suggesting that
incomplete C-Frag could serve as the initial event responsible for forms of genome chaos including chromothripsis. In addition,
multiple cell death types are shown to coexist with C-Frag and it is more dominant than apoptosis at lower drug concentrations.
Together, this study suggests that cell death is a diverse group of highly heterogeneous events that are linked to stress-induced
system instability and evolutionary potential.
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Cellular stress has been implicated in many diseases,
including cancer. During cancer progression, cellular stress
promotes adaptive genome alterations, which increase the
probability of somatic evolution.
1 Multiple types of stress have
been documented occurring through various molecular
mechanisms, and some are linked to genome instability
and apoptosis.
2,3 However, cell death occurs in a number of
forms, and apoptosis does not adequately represent the
amount of cell death that happens in tumors in response to
chemotherapy or radiation.
4 Apoptosis tends to occur in
response to relatively high levels of drug treatment, often
higher than clinical levels,
5 and the exact functions of
apoptotic proteins can be contextually dependent. For
example, in some cases activation of apoptotic proteins may
drive proliferation. Furthermore, tumor cells often overex-
press antiapoptotic proteins or lack intact cell-cycle check-
points.
6 Loss of checkpoint function allows the cells to
progress to mitosis despite the presence of damaged DNA,
often resulting in mitotic cell death (MCD).
Although MCD accounts for the majority of tumor cell death
during treatment, its mechanism(s) is largely unknown.
5,7–9
MCD appears as at least two major phenotypes: One is
mitosis associated cell death, which occurs following abnormal
segregation, where death takes place in G1 following
abnormal division. This form of MCD is associated with
classical apoptosis, as the caspase cascade is activated
following entry of multinucleated cells into G1, and is referred
to as mitotic catastrophe (MC).
9,10 Another is chromosome
fragmentation (C-Frag) that occursdirectly during mitosis. It is
readily identiﬁable in cytogenomic ﬁgures where degraded
chromosomes are evident.
9
To illustrate the basis of C-Frag, many diverse stresses
leadingtoC-Fragareanalyzed.Asimplerelationshipbetween
diverse system stresses and C-Frag is established. These
stresses are shown to converge on the induction of centro-
some ampliﬁcation, a major component in the regulation of
genome stability. Based on this relationship, the common
mechanism of cell death is re-synthesized: (1) Cell death is a
generalresponseofthecellularsystemtostress,havingarole
in rebalancing the cellular system. C-Frag, a main phenotype
of MCD, is achieved through an array of individual molecular
mechanisms, including centrosome ampliﬁcation. (2) The
type of cell death that will dominate in a given sample is
dependentonmultiplefactors,includingtheavailabilityofboth
the targets in cells (checkpoint function, whether cells are
actively dividing) and the speciﬁcs of drug treatment. (3) The
types of cell death induced are heterogeneous, as shown by
cytogenomic analysis. Such heterogeneity, in addition to
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11,12 explains why drug treat-
ment can favor cancer evolution, as treatment induces stress
leading to genome-mediated cancer evolution.
1,13 Recent
reports have detailed processes where cassettes of fragmen-
ted chromosomes have been rejoined to form highly
recombined chromosomes.
11,14,15 This process can affect a
small number of chromosomes or nearly the entire genome,
resulting in the induction of genomic instability, formation of
new genome systems, and providing material for genome-
based cancer evolution. Owing to the associations between
C-Frag, genomic instability, disease progression, and the
intervention of chemotherapies, this work underscores the
potential of using C-Frag as a diagnostic tool in clinical
settings.
Results
Realizing the underlying complexity of cell death processes,
wehaveattemptedtousemultiple,diversesystemsinorderto
determine the common mechanism(s) of C-Frag, which
contrasts the traditional approach of using the same system
to study different aspects.
PARP cleavage is associated with C-Frag. In multiple
forms of cell death, DNA is degraded before stores of ATP
are depleted; however, proteins such as PARP could repair
the degrading DNA.
16 DNA repair is avoided through the
degradation of PARP by a broad range of proteases.
16
Therefore, PARP cleavage was analyzed during the process
of C-Frag and PARP was readily degraded (Figure 1a).
C-Frag differs from MC. To compare MC and C-Frag,
a well-described model of MC was analyzed for C-Frag.
17
Cytogenomic analysis shows that, in contrast to previous
reports, the mitotic fraction of cells actually decreases,
suggesting that this form of MC is not mitotic in origin
(Figure 1b). During treatment cells became enlarged
(Figure 1c) and began to die. Over the course of treatment,
the frequency of C-Frag did increase, but not enough to
account for the amount of cell death previously reported,
showing the difference between C-Frag and MC (Figure 1b).
Previous studies have focused on the G2/M based on DNA
content alone.
17 It is thus possible that the death observed
previously was associated with cells in G2. The main
morphologies observed during MC include apoptotic cells,
multinucleated cells, and cells undergoing C-Frag
(Figure 1d).
G2 checkpoint abrogation through loss or reduction of gene
function may result in increased C-Frag. UCN-01, which
ameliorates G2 checkpoint function, has a cooperative effect
with many other chemotherapeutics, likely through induction
of mitotic death.
18 To determine whether this death is
correlated with C-Frag, HCT116 cells were treated with
UCN-01 and doxorubicin (Dox). Treatment resulted in the
Figure 1 (a) Induction of C-Frag in H460-neo- and H460-Bcl-2-overexpressing cells by concurrent 12-h treatment with colcemid and Dox results in complete cleavage of
PARP. Bcl-2-overexpressing and control cells were used to show that PARP degradation is not caused by apoptotic death in the case of C-Frag. (b–d) HCT116 14-3-3s
 / 
cellstreatedwith0.2mg/mlDoxhavebeenshowntodiethroughMC.
17Seventy-twohoursoftreatmentresultsinthemitoticindexfallingtoalmost0(orangeline),whereasthe
percentage of multi-nucleated/multi-lobulated cellsincreasessigniﬁcantly(blueline) andthepercentageof apoptoticcellsrises slightly(red line) (b).During thistimethere isa
degradationofcellularmorphologyascellsenlargeanddie,andinagreementwithpreviousresults,by72happroximately90%ofcellsdied(c).
17Inpreviousreports,thebulk
of cell death was thought to be occurring in mitotic cells; however, we were unable to identify such population by cytogenomic analysis, suggesting that this death may not be
attributable to mitosis. (d) Examples of C-Frag, apoptotic, and multi-lobulated/nucleated cells are shown on the left, the middle, and the right, respectively following
conventional cytogenetic preparation
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Cell Death and Diseaseinduction of C-Frag in 36.3% of mitotic cells following 300nM
UCN-01 and 1mg/ml Dox treatment for 6h. By contrast, cells
treated with UCN-01 or Dox alone showed a C-Frag index (CFI)
of 7.2 and 9.4%, respectively, showing that abnormal passage
of damaged cells from G2 to mitosis can result in C-Frag.
Clinical relevance of C-Frag. C-Frag was mainly
characterized using in vitro cell culture models.
9 C-Frag
was detected in mouse xenograft tumors without culture.
C-Frag (Figure 2a) is distinguishable from normal mitotic
cells (Figure 2b). We next determined the potential clinical
utility of C-Frag. Tumors were analyzed from a number of
cancer types, including short-term cultured solid tumors and
peripheral lymphocytes from patients with hematological
malignancies, and C-Frag was found to occur in all the
samples (Stevens et al., unpublished data).
Linking C-Frag to various types of stresses. According to
the genome theory,
1,11–13,19,20 genome system instability can be
induced by various stresses, including disease conditions; we
thus hypothesize that system stress might represent the
underlying mechanism of C-Frag. Both internal and induced
stresses were examined using diverse experimental systems.
Genomic instability leads to C-Frag. C-Frag was monitored
in the early and late stages of a model of spontaneous in vitro
immortalization (MDAH-041) and mouse ovarian surface
epithelial cell (MOSEC) model progression.
11,13 In the
MDAH-041 model, the spontaneous C-Frag index (CFI)
mirrors overall genomic instability as measured by non-clonal
chromosome aberrations (NCCAs). The CFI is 6% at pd25,
whereas once the cells stabilize at pd54 the CFI falls to 2.9%
(Figure 3a). In the MOSEC model, early-stage (p9) cells have
high levels of genomic instability, whereas at later stages (p91)
the cells become more clonal.
13 In the early stages, these cells
had a moderate frequency of spontaneous C-Frag (8.8%),
whereas in the late stable stages this reduced to 0.8%.
Genomic instability is linked to the generation of C-Frag.
Culture stress induces C-Frag. C-Frag was ﬁrst analyzed in
response to temperature changes. COLO-357 cells were
cultured at 371C and then shifted to 421C for 2 weeks before
being switched back to 371C (Figure 3b). When shifted from
37 to 421C, the cells showed an increase in CFI within 24h of
shifting (Po0.01). The CFI stabilized at o6% within 120h of
the switch. The cells stabilized at 421C were switched back to
371C and showed an increase in the CFI (P¼0.042) until it
fell to o5% within 120h. The observation that switching cells
stabilized at 421C back to the ‘normal’ temperature of 371C
induces C-Frag is signiﬁcant. It suggests that any change to
the current system status is a key source of stress, and that
cell death is one mechanism of system adaptation.
Most cell culture uses atmospheric oxygen concentrations
(20%), whereas in vivo cells rarely experience over 3.5%
O2.
21 HCT116 cells were acclimated for 5 days to 3.5%
oxygen. For the ﬁrst 3–4 days population doubling slowed or
stopped, until cells began to once again cycle regularly.
Concurrent treatmentof theseacclimatized cellswith Doxand
colcemid resulted in a CFI of 54.7%, which is lower than the
typically observed CFIs for HCT116 cells (nearly 100%) with
the same treatment at atmospheric oxygen. Thus, similar to
other forms of programmed cell death,
21 a normoxic environ-
ment suppresses C-Frag as compared with a hyperoxic
environment.
ER stress induces C-Frag. Multiple pathways regulate
various endoplasmic reticulum (ER) stress response
pathways, including calcium stress, unfolded protein
response, and oxidative stress.
22 To determine whether
these speciﬁc stress pathways could lead to C-Frag, COLO-357
cells were treated with various inducers of ER stress.
Treatment with dithiothreitol (DTT), which induces the
unfolded protein response by interfering with protein
folding, strongly induced C-Frag (Figure 3c). Treatment
with thapsigargin (TG) and tunicamycin (TM) also
increased the CFI, whereas A23187 did not, instead
completely blocking entry into mitosis. All four drugs
induced the unfolded protein response (Figure 3d). The
differential frequencies of C-Frag and apoptosis between
these treatments suggest that the type of cell death depends
on the availability of the targets, as with A23187 treatment
there were no mitotic cells providing material for C-Frag.
Inhibition of HSP90 increases chromosome fragmentation.
Heat-shock proteins (HSPs) respond to cellular stress and
HSP90 speciﬁcally functions in a multitude of stress
pathways. To determine whether HSP90 function may have
a role in C-Frag, cells were cultured using varying con-
centrations of Dox that would arrest the cell-cycle and
deplete mitotic cells required for C-Frag. The cells were then
treated with 17-DMAG (water-soluble geldanamycin analog),
a potent HSP90 inhibitor. This resulted in an increase in the
frequency of C-Frag (Figure 3g), indicating that inhibition of
major stress pathways predisposes cells to death.
Figure 2 C-Frag is detectable in in vivo tumors prepared for cytogenomic analysis (a). Here, two examples of cells undergoing C-Frag from an untreated primary mouse
tumor are shown (left and right panels). In the photo on the right the cell on the top left is an example of a defective mitotic ﬁgure (DMF) that is also undergoing C-Frag.
12 The
morphology of C-Frag is readily distinguishable from the normal mitotic ﬁgures of the same tumor (b)
System stresses lead to chromosome fragmentation
JB Stevens et al
3
Cell Death and DiseaseCentrosome ampliﬁcation occurs in cells treated to
undergo C-Frag. Centrosome ampliﬁcation has been
linked to temperature stress-induced MCD.
23 Association of
centrosome ampliﬁcation with C-Frag may help to elucidate
its mechanisms. In non-treated HCT116 cells, 21.3% of
mitotic cells show three or more centrosomes (Figures
3e and f). By contrast, cells treated concurrently for 12h
with colcemid and 1mg/ml Dox showed centrosome
ampliﬁcation in 51.7% of mitotic cells (P¼0.021).
Furthermore, ATM
 /  mouse cells were shown previously
to exhibit centrosome ampliﬁcation.
24 C-Frag was found to
be present in embryonic ﬁbroblasts and lymphocytes from
these mice (data not shown). Thus, there is linkage between
abnormal centrosome counts and increased C-Frag.
HSP90 is a core centrosome component, suppresses
centrosome instability, and is linked to MCD.
25 In addition to
observing increased centrosome ampliﬁcation during C-Frag,
it increased in association with HSP90 inhibition. Centrosome
instability is also associated with genomic instability, a form of
system stress that is capable of inducing C-Frag. It is thus
likely that centrosome ampliﬁcation is a response to stress
and mechanistically links stress to MCD.
The relationship between C-Frag and other types of cell
death. ER stress has been previously linked to cell death by
apoptosis. Our current study also links ER stress to C-Frag;
however, C-Frag and apoptosis likely use different
mechanisms.
9 Traditional studies focus on one type of cell
Figure 3 The effects of various stressors on C-Frag are examined (*Po0.05, **Po0.01, ***Po0.001) (a–c). (a) C-Frag is elevated during genomic instability (pd25)
(blue bar) as compared with stable genomes (pd54) (green bar, Po0.05). (b) Increasing the culture temperature of COLO-357 cells from 37 to 421C (blue line) results in a
transient increase in the frequency of C-Frag until spontaneous C-Frag falls to 46%. Following the shift of temperature back to 371C (green line) there is another
corresponding increase in the CFI, which then stabilizes at o5%. Statistical signiﬁcance was calculated by comparing each time point to the 0 time point of the treatment.
(c) Treatment of COLO-357 cells with speciﬁc stress inducers, including DTT (blue line), TG (red line), and TM (green line), results in varied increased C-Frag over a 24-h
period. The error bars represent the standard deviation. (d) Western blot analysis of the same DTT and TG treatments show an increase in the expression of CHOP, a key
proteinintheERstressresponse.CHOPexpressionincreasessteadilyinbothTGandDTTtreatmentsfrom0to8h,thenfallsoffat24hascellsadapttothestress.Activated
XBP1 expression changes similarly in DTT-treated cells, whereas TG treatment results in little expression. Finally, there is an increase in ER proteins bearing the ER
translocation sequence KDEL from 0 to 24h of treatment, which is indicative of ER stress (d). Concurrent treatment with colcemid and Dox to induce C-Frag in HCT116 cells
results in increased centrosome ampliﬁcation (e). (f) An example of centrosome ampliﬁcation (right panel, arrowheads) taking place in a cell undergoing C-Frag (left panel,
arrowhead).Multiplecentrosomesaredetectable(arrowheads),whereasinanormalneighboringcellundergoingmitosis(leftpanel,arrow),onlytwocentrosomesarepresent
(right panel, arrows). Inhibition of HSP90 function with 17-DMAG results in increased C-Frag (g). Bars represent the CFI of cells treated with or without (control – blue bar)
doxorubicin at the indicated concentration for 54 h. After 24 h of treatment 100nM 17-DMAG was added followed by the addition of colcemid 6 h prior to harvest. Doxorubicin
treatmentat1mMand1mg/ml(orangeandpurplebarsrespectively)wouldtypicallyresultincellcyclearrestanddeathviaapoptosisornecrosis,however17-DMAGtreatment
allowscellstoprogresstomitosiswithdamage.DamagedmitoticcellsaretheneliminatedbyC-Frag.Treatmentwith50nM(redbar)and150nM(greenbar)elevatestheCFI,
however many cells do not contain sufﬁcient damage to induce C-Frag
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Cell Death and Diseasedeath, linking it to one speciﬁc molecular mechanism when
there are likely multiple forms of cell death occurring. The
above diverse response between C-Frag, apoptosis, and
various drugs that induce ER stress suggests an
interchangeable relationship among types of cell death,
prompting further study of the relationships between
various mechanisms and different types of cell death
(Table 1).
Heterogeneity of cell death types. HCT116 cells were
treated with various combinations of drugs at various
concentrations. The type of cell death incurred was scored
by cytogenomic analysis where C-Frag and apoptosis are
distinguishable (Table 1 and Figures 4a and b). Although the
occurrence of apoptosis during mitosis has not been
established, a general lack of morphological descriptions of
mitotic apoptosis suggests that it may not occur. It is note-
worthy that apoptotic cells can be detected in populations
where C-Frag is the primary form of cell death, and vice
versa. For individual cells, cell death is an occurrence of
opportunity, and the form of cell death is contingent on the
genome status and environmental conditions.
Cell death type is inﬂuenced by dosage of drug
treatment. Effects of drug concentration on death type
were examined, as the required dosage for inducing
apoptosis is often higher than what is clinically
obtainable.
8,26 For colcemid-based combinations of
treatments, Dox at 10 and 1mg/ml potently, but to different
degrees, induces C-Frag. Mitomycin-C (MMC) treatment at
10mg/ml is also capable of increasing the frequencies of
C-Frag, whereas 1mg/ml MMC, and 10 and 1mg/ml
methotrexate (MTX) treatment do not induce C-Frag at
appreciable levels. Surprisingly, none of these treatments
induced more than 2% apoptosis, based on morphological
analysis suggesting that in this in vitro cancer system, C-Frag
is the major form of cell death. The lack of apoptosis could be
because of the length of treatment, as 6h of treatment may be
insufﬁcient to induce late-stage apoptosis where apoptotic
cells are identiﬁable by morphology.
In the case of docetaxel and Dox combinatorial treatments,
ah ig hc on c e nt ra ti o n(1 0mM)of docetaxel combined with 1mg/ml
Dox increased the apoptotic response, whereas low concen-
trations (1mM) of docetaxel and 1mg/ml Dox primarily resulted
in cell death by C-Frag (Figure 4b). Although the observed
levels of cell death are often less than 5%, this number
represents the population as a whole, the majority of which is
non-mitotic. The majority of the mitotic cells are therefore
undergoing C-Frag. Similarly, treatment with low concentra-
tions of Dox and 100nM 17-DMAG primarily results in cell
death through C-Frag; however, at increased doses of Dox
apoptosis increases (Figure 3g).
C-Frag is linked to increased proteasomal activity. The
H1299-v138 cell line contains a temperature-sensitive p53
mutation.
9 Shifting these cells from 39 to 321C results in
C-Frag.
9 To establish the relationship between different
types of cell death, proteasome activity was measured at day
0 (restrictive temperature) until day 3 (days 1–3, permissive
temperature) over which time the majority of cell death takes
place. From day 0 to day 2 proteasome activity increased
1.79-fold. Proteasomal activity correlates with the induction
of C-Frag (r
2¼0.768), showing that induction of C-Frag is
also linked to a major mechanism of protein degradation,
which is strongly associated with cell death.
27
Discussion
C-Frag is a stress response. C-Frag is a general response
to diverse stress. The association of C-Frag with broad-
ranging factors suggests that the dynamics of a complex
system is not likely explained by only one speciﬁc molecular
mechanism. The concept presented here ﬁnally solves a
mystery of the phenomenon of chromosome pulverization.
Table 1 Nuclear features of types of cell death
Type of death Cytogenomic features
Apoptosis Nuclear blebbing resulting in grape-like
clusters
Necrosis Nuclear shrinkage (pyknosis)
Autophagy Little if any change in nuclear morphology
Chromosome
fragmentation
Degradation of condensed mitotic
chromosomes
Figure 4 Different treatment combinations result in different outcomes.
Concurrent treatment of HCT116 cells with colcemid and Dox, mitomycin-C
(MMC),or methotrexate(MTX)result ina variedinductionofcelldeathbyapoptosis
(green bars) and C-Frag (blue bars) as judged by cytogenetic examination (a).
Treatment of cells with docetaxel instead of colcemid results in mitotic arrest as
expected, combinatorial treatment with 1mg/ml Dox and either 1mM docetaxel or
10mMdocetaxelresultsprimarilyinC-Fragorapoptosis,respectively(b).Asjudged
by previous work, some of the values for apoptotic death observed here were lower
than what has been shown previously. This is likely because of differences in
cytogenomic assays as compared with molecular assays to identify apoptosis such
as TUNEL, which may be more sensitive
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Cell Death and DiseaseFor decades, the mechanism of chromosome pulverization
has been linked to various speciﬁc causative factors such as
viral vaccination, defective genes, and environmental
challenges.
28–31 C-Frag (erroneously termed premature
chromosome condensation (PCC)) has been linked
exclusively to single molecular mechanisms without the
realization that induction of MCD is a common response to
stress.
20 This current study shows that the underlying
general cause of this long observed phenomenon is system
stress rather than a speciﬁc gene-associated phenomenon
(Table 2). This conclusion also shows that multiple response
pathways should be monitored in other apoptosis and
molecular pathway research.
Thestress–C-Fraglinkissigniﬁcant.Stressisamajordriver
of genomic instability-mediated cancer evolution.
1 Genome
change occurs as an adaptive response to stress, increasing
population diversity, the probability of survival, and potentially
the acquisition of new features essential for cancer progres-
sion and drug resistance. Recently, examples of extreme
genome change (genome chaos) within tumors have been
reported, where multiple intra- and inter-region arrangements
of chromosomes occur.
11,14,15 It has been suggested that
these events are the result of local chromosome shatter-
ing,
14,15 although C-Frag could function as a necessary step.
C-Frag has been shown to occur in one or a small number of
chromosomes,
9whichreconcileswhyonlyalimitednumberof
chromosomes canbe involved in cases ofgenome chaos.We
have also observed genome chaos in multiple cell lines in
response to stress (Heng et al., unpublished results). As
C-Frag is linked to stress, it is likely that these two events
occur together.
C-Frag and centrosome ampliﬁcation. As C-Frag occurs
at mitosis, it is ideal to search for the mechanism leading to it
within this time window. Centrosome ampliﬁcation often
results in multi-polar divisions, which can cause aneuploidy
or can result in cell death.
32 Heat shock or inhibition of HSP
activity can induce MCD consequent to centrosome
ampliﬁcation.
23,31,33 HSP90 induction can be linked to
broad stressors such as temperature shift and chemo-
therapeutics, as it is a core component of the centrosome
that functions in a number of pathways, including the Chk1
pathway, which has a central role in the G2 checkpoint.
Ablation of HSP90 function increases the mitotic index and
cell death during mitosis, largely by C-Frag, while correlating
with increased centrosome ampliﬁcation, suggesting a direct
link between stress, centrosome ampliﬁcation, and C-Frag.
Furthermore, centrosome ampliﬁcation has also been linked
to wound healing, development of polyploid liver cells,
genomic instability, and cancer.
32 These responses can
also be linked to C-Frag; thus, we conclude that C-Frag
simply represents one of the main phenotypes of cells that
have undergone ‘cell death occurring during metaphase’.
9,34
We now propose a general model of C-Frag. Various
cellular stresses can act on the mitotic machinery, such as the
centrosome, and abnormal function of mitotic systems leads
to C-Frag. In other words, centrosome ampliﬁcation-induced
mitotic failure leads to a C-Frag phenotype. As centrosomes
represent major parts of the mitotic machinery, we anticipate
that other important components of mitosis could also be
responsible for subtypes of cell death.
13 Inhibition of HSP90
reinforces these results as HSP90 has a pivotal role in
centrosome stability, and its inhibition leads to increased
C-Frag.
Potential diagnostic and prognostic uses of C-Frag. One
problem with the use of apoptosis in disease treatment has
been the observation that drug concentrations that often
induce apoptosis in experimental systems do not seem to
induce apoptosis in clinical settings, unless much higher
concentrations are used.
8 Our study shows that C-Frag can
account for a portion of this disparity. Another important
ﬁnding is the link between elevated C-Frag frequency and
various disease conditions. C-Frag was shown to occur
broadly across many types of tumors, underscoring that
C-Frag is not a cell line- or gene-speciﬁc phenomenon, but
rather a general response that is inﬂuenced by pathological
stress to eliminate cells and maintain system stability. Further
clinical investigation is needed to link elevated C-Frag to
speciﬁc clinical conditions.
Induction of a speciﬁc type of cell death is largely
dependent on convenience. Our data suggest that cell
death is a highly complex process, and multiple forms of cell
death result from a simple response to overwhelming
stress(es). Whenever a population of cells is stressed
sufﬁciently to induce death, it is likely that more than one
type of cell death will be induced owing to the heterogeneous
Table 2 Diverse mechanisms of C-Frag
References
Speciﬁc mechanism of C-Frag
Caffeine uncoupling of the cell cycle 40
Chromosome-localized UV damage 30
Loss of ATM function Current study
Loss of ATR function 28
Loss of p53 function 29
Measles vaccination 41
Stresses
Calcium Current study
Genomic instability Current study
HSP inhibition Current study; 23
Oxidative Current study
Temperature change Current study; 23, 31
Unfolded protein response Current study
Drugs
Arsenic trioxide 23, 31
Cytosine arabinoside Current study
Colcemid 9
Docetaxel Current study
Doxorubicin 9
Methotrexate 9
Mitomycin-C Current study
Pathological conditions
Breast cancer Current study
Brain malignancies Current study
Hematological malignancies Current study
Lipoma Current study
Leukocytosis Current study
Mitotic components
Centrosome ampliﬁcation Current study
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Cell Death and Diseasemeans of eliminating unwanted cells. One speciﬁc form of
cell death may dominate in speciﬁc instances, although sub-
populations will likely undergo other terminal fates. The cell
death type is highly dependent on multiple factors, including
the original cell population, the type and amount of stress
incurred, and the availability of targets. For instance, cancer
cells are highly mitotic as compared with normal somatic
cells, making mitotic cells an increasingly likely target.
Unfortunately, common molecular methods such as
western blotting only identify changes in an admixture of
cells, but do not show variation on the single-cell level.
Echoing other reports, our results showing cell death
heterogeneity underscore the importance of individual cell-
based analyses.
1,8,12,35
Following the demonstration that the different tested
stressors can induce C-Frag, it was determined that
system stress represents the general mechanisms of
C-Frag. The approach here differs from traditional
approaches where a speciﬁc molecular pathway is identiﬁed
in order to study a mechanism. However, for any given
complex system, general mechanisms can be understood
using the synthesis of the large number of speciﬁc mechan-
isms.
1,12 Further synthesis led us to conclude that stress can
induce all types of cell death and that stress is not speciﬁc for
C-Frag. Such a conclusion complements the traditional
approaches of cell death research that focus on speciﬁc
molecular pathways.
To illustrate the general mechanism of cell death, we
present a model suggesting a link between diverse molecular
mechanisms, maintenance of genome integrity, system
stress, and various types of cell death (Figure 5). This is
similar to the relationship between the evolutionary mechan-
ism of cancer and all individual molecular mechanisms.
1,19 All
individual molecular mechanisms can be linked to system
stress in a stochastic manner. The relationship above
illustrated between system stress, C-Frag, cell death, and
genome alteration shows a portion of the complex means for
maintaining genome stability and yet creating new genomes,
which ﬁts well within the system biology concept where
system dynamics and stability can be achieved through vastly
different individual molecular mechanisms. Knowing that
various types of cell death can be induced by stress and
coexist within heterogeneous cell populations, it is not
surprising to identify the association between C-Frag and
other forms of cell death. It is also possible that C-Frag can be
linked to apoptosis or/and autophagy under certain conditions
in terms of speciﬁc molecular pathways. However, C-Frag
represents an independent form of MCD.
It should be pointed out that certain types of cell death tend
to dominate in a given analysis. This is because of system
complexity and high levels of cellular heterogeneity affecting
cell death selection, and may help explain many of the
inconsistencies of MCD. For instance, in some cases it has
been shown contrastingly to be both caspase-dependent and
-independent.
9,31,36,37 It is quite possible that C-Frag and
other subtypes of MCD coexist, and some subtypes can be
linked to caspase activity. In our system, we have monitored a
deﬁned window of mitosis based on cytogenomic analysis,
reducing the chance of including other types of cell death
when scoring C-Frag. Moreover, the different systems
examined show different pathways that can all lead to MCD.
Finally, C-Frag represents a powerful means to create a new
system during crises stages of somatic evolution.
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Materials and Methods
Cell culture. Cell lines were grown in RPMI-1640 (Hyclone, South Logan, UT,
USA)mediasupplementedwith10%fetalbovineserum(FBS)(Hyclone)in5%CO2
at 371C unless otherwisenoted. HCT116 14-3-3s
 / , H460, and H1299-v138 cells
were grown with 400mg/ml G418 (Fisher Scientiﬁc, Pittsburgh, PA, USA). The cell
lines used in the following experiments were chosen because of their genetic
manipulations. The cell lines that have not been modiﬁed were selected as they are
notabnormallyproneorresistanttoC-Frag.Theiridentitywasconﬁrmedbyspectral
karyotyping within 6 months of use (Supplementary Table S1). The HCT116,
H1299-v138, and COLO-357 cell lines were provided by Drs. Bert Vogelstein, Yi
Sun, and Anton Goustin, respectively.
Isolation of cells from mouse tumors. Following resection, tumors were
minced ﬁnely in PBS. Visible chunks of tumor were then digested in a trypsin
solution (Hyclone) and drawn through a 25G needle until chunks were separated.
The trypsin was then quenched with FBS and the two portions of the cells were
mixed back together and forced through a 30-mm nylon screen to remove any
remaining clumps.
Chromosome preparation from cell lines, cultured lymphocytes,
and solid tumors. Cytogenomic preparation performed as described by
Ye et al.
13 Brieﬂy, cells were harvested, pelleted, suspended in 0.4% KCl for 20min
at 371C, ﬁxed in 3:1 methanol:acetic acid, and dropped onto ice-cold glass slides.
Theslideswerethenstainedfor15minatroomtemperaturein2%Giemsasolution.
Slide scoring. Slides were scored for C-Frag as described previously;
9 brieﬂy,
mitoticﬁgureswereobservedandcellswith chromosomal degradation consistent to
whatwaspreviouslyscoredasC-Fragwerecounted.
9FortreatmentswheretheCFI
was shown, only mitotic cells were scored. CFI was calculated by dividing the
number of cells undergoing C-Frag by the total number of mitotic cells counted.
Western blotting. Western blotting analysis was performed as described by
Xu et al.
39 To determine expression levels of CHOP, KDEL, XBP1 and a-tubulin
total cell lysates were prepared from treated COLO-357 cells using NP-40
lysis buffer (1% NP-40, 50mM Tris-HCL pH 7.5, 150mM NaCl, 0.05% SDS,
0.5mM Na vanadate, 100mM NaF, 50mM b-glycerophosphate, and 1mM
Figure 5 A proposed model illustrating the relationship between stress and the induction of various types of cell death. When a cell faces a given stress that is strong
enough to induce death, multiple factors inﬂuence the selection of the speciﬁc pathways of cell death and depend on the availability of targets (mitotic or interphase cells)
and/or the availability of certain pathways
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Cell Death and Diseasephenylmethylsulfonyl ﬂuoride) supplemented with protease inhibitors (EDTA-free
Complete Mini, Roche, San Francisco, CA, USA). Denatured proteins were
separated by SDS-PAGE on 10% Tris-glycine polyacrylamide gels and transferred
to a 0.45mm PVDF membrane (GE Healthcare, Waukesha, WI, USA). Detection
was performed with CHOP (Santa Cruz Biotech, Santa Cruz, CA, USA), KDEL
(Enzo Life Sciences, PlymouthMeeting, PA, USA), XBP1(Santa Cruz Biotech) and
a-tubulin (Sigma-Aldrich, St Louis, MO, USA) antibodies at manufacturers
suggested concentrations. HRP conjugated Rabbit TrueBlot secondary antibody
(eBioscience, San Diego, CA, USA) was used for secondary diction as is avoids
detecting the Ig heavy and light chains from denatured samples. Bound antibody
was detected using enhanced chemiluminescence (ECL) reagent or ECL Plus
reagent (GE Healthcare) according to the manufacturer’s protocol.
Induction of MC. MC was induced as described by Chan et al.
17 HCT116
14-3-3s
–/– cells were treated for up to 72h with 0.2mg/ml Dox, photographed,
harvested, and subjected to cytogenetic preparation and analysis at the indicated
intervals.
Abrogation of G2 checkpoint by UCN-01 treatment. HCT116 cells
were treated concurrently with 1mg/ml Dox and 300nM UCN-01 (Sigma-Aldrich) for 6h.
Normoxic treatment. HCT116 cells were grown in a hypoxic chamber with
3.5%O2and5%CO2,andacclimatizedfor5daysuntilcellswereactivelydividing.The
cellswerethenpretreatedfor3hwithcolcemid,amitoticshake-offwasperformed,and
the cells were treated for 6 or 12h with 1mg/ml Dox under colcemid pressure.
Temperature shift. COLO-357 cells were cultured at 371C and then cultured
at421Cfor10daysatwhichtimecellsstabilizedandbegantogrowagain.Thecells
were then transferred back to 371C and harvested at the indicated time points
(Figures 3a and b).
Linking C-Frag and genomic instability. MDAH-041 and MOSEC cells
were harvested during different time periods where the population showed genome
stability and instability as determined by spectral karyotyping (SKY), and prepared
for cytogenomic evaluation.
11,13
Induction of pathway-deﬁned stress. COLO-357 cells were treated
threeindependenttimesfor4,8,and24hwiththeERstressinducersA23187,DTT,
TG, and TM (Sigma-Aldrich).
Centrosome ampliﬁcation. Cells were attached to glass slides using a
ShandonCytospin at 1000 r.p.m. for 5min, ﬁxed for 7min in 1% paraformaldehyde,
permeabilized with 0.1% Triton X-100, incubated with a g-tubulin antibody (Abcam,
Cambridge, MA, USA), washed, incubated with an Alexa-Fluor-488-labeled anti-
mouse antibody (Invitrogen, Carlsbad, CA, USA), washed, coverslipped with DAPI
and anti-fade (Invitrogen), and imaged.
Inhibition of HSP90. HCT116 cells were treated for a total of 54h with Dox
(50nM, 150nM, 1mM, or 1mg/ml); after 24h of treatment, 100nM 17-DMAG (LC
Laboratories, Woburn, MA, USA) was added to the cells. Following a 24-h
incubation of 17-DMAG and Dox, 1  colcemid was added for 6h prior to harvest.
Proteasomal activity assay. Proteosomal activity was measured as
previously described.
33 Cells were washed 3 times with ice-cold PBS and scraped
for centrifugation. Cell pellets were resuspended in lysis buffer (50mM Tris-Cl, pH 7.5,
10mM MgCl2, 100mM KCl, 1% Triton X-100, 10% glycerol, 1mM DTT, 1X protease
inhibitor cocktail) and mixed with rotation at 41C for 2h. Extract was centrifuged at
13200 rpm for 10min at 41C. Protein concentration was determined using Bradford
Assay Kit (Bio-Rad, Hercules, CA, USA). Chymotrypsin-like activity of the 20S
proteasomewasmeasuredbyincubationof40mMSuc-Leu-Leu-Val-Tyr-AMC(Boston
BioChem, Cambridge, MA, USA) with 20 mg cellextract in100 ml assay buffer (50mM
Tris-Cl,pH7.5)at 371Cfor1h. Thereleasedﬂuorescencesignalsweremonitoredwith
an excitation ﬁlter of 355nm and an emission ﬁlter of 460nm using VersaFluot
Fluorometer (Bio-Rad).
Differential induction of apoptosis and C-Frag. HCT116 cells were
treated for 6 and 12h with 1mg/ml Dox (MP Biochemicals, Solon, OH, USA), 1mM
docetaxel (MP Biochemicals), 10mM docetaxel, and 1 or 10mM docetaxel
combined with 1mg/ml Dox.
Statistical analysis. Paired t-tests were performed using Microsoft Excel.
Conﬂict of Interest
The authors declare no conﬂict of interest
Acknowledgements. This manuscript is part of a series of studies entitled
‘Themechanismofsomaticandorganismalevolution’.WethankDr.BertVogelstein
fortheHCT116andHCT11614-3-3
 / celllines,Dr.YiSunfortheH1299-v138cell
line, and Dr. Anton Goustin for the COLO-357 cell line. This work was partially
supported by grants to HHQH from the Komen Foundation, SeeDNA Inc., and the
USDepartmentofDefense(GW093028);andgrantstoKZbytheUSDepartmentof
Defense (BC095179P1). JBS was supported by a WSU CMMG post-doctoral
fellowship. WealsothankDrs.AlexGowandJamesTuckerfor valuablediscussion.
1. Heng HH, Stevens JB, Bremer SW, Ye KJ, Liu G, Ye CJ. The evolutionary mechanism of
cancer. J Cell Biochem 2010; 109: 1072–1084.
2. Negrini S, Gorgoulis VG, Halazonetis TD. Genomic instability – an evolving hallmark of
cancer. Nat Rev Mol Cell Biol 2010; 11: 220–228.
3. Tabas I, Ron D. Integrating the mechanisms of apoptosis induced by endoplasmic
reticulum stress. Nat Cell Biol 2011; 13: 184–190.
4. Brown JM, Wouters BG. Apoptosis, p53, and tumor cell sensitivity to anticancer agents.
Cancer Res 1999; 59: 1391–1399.
5. Park SS, Kim MA, Eom Y-W, Choi KS. Bcl-xL blocks high dose doxorubicin-induced
apoptosis but not low dose doxorubicin-induced cell death through mitotic catastrophe.
Biochem Biophys Res Commun 2007; 363: 1044–1049.
6. Blagosklonny MV. Apoptosis, proliferation, differentiation: in search of the order. Semin
Cancer Biol 2003; 13: 97–105.
7. Kondo S. Altruistic cell death: mitotic catastrophe model of apoptosis. Protein Nucleic Acid
Enzyme 1994; 39: 2238–2245.
8. Roninson IB, Broude EV, Chang BD. If not apoptosis, then what? – Treatment-induced
senescence and mitotic catastrophe in tumor cells. Drug Resist Updat 2001; 4: 303–313.
9. Stevens JB, Liu G, Bremer SW, Ye KJ, Xu W, Xu J et al. Mitotic cell death by chromosome
fragmentation. Cancer Res 2007; 67: 7686–7694.
10. Castedo M, Perfettini JL, Roumier T, Kroemer G. Cyclin-dependent kinase-1: linking
apoptosis to cell cycle and mitotic catastrophe. Cell Death Differ 2002; 9: 1287–1293.
11. Heng HH, Stevens JB, Liu G, Bremer SW, Ye KJ, Reddy PV et al. Stochastic cancer
progression driven by non-clonal chromosome aberrations. J Cell Physiol 2006; 208:
461–472.
12. Heng HH, Bremer SW, Stevens JB, Ye KJ, Liu G, Ye CJ. Genetic and
epigenetic heterogeneity in cancer: a genome-centric perspective. J Cell Physiol 2009;
220: 538–547.
13. Ye CJ, Stevens JB, Liu G, Bremer SW, Jaiswal AS, Ye KJ et al. Genome based cell
population heterogeneity promotes tumorigenicity: the evolutionary mechanism of cancer.
J Cell Physiol 2009; 219: 288–300.
14. Berger MF, Lawrence MS, Demichelis F, Drier Y, Cibulskis K, Sivachenko AY et al. The
genomic complexity of primary human prostate cancer. Nature 2011; 470: 214–220.
15. Stephens PJ, Greenman CD, Fu B, Yang F, Bignell GR, Mudie LJ et al. Massive genomic
rearrangement acquired in a single catastrophic event during cancer development.
Cell 2011; 144: 27–40.
16. Borst P, Rottenberg S. Cancer cell death by programmed necrosis? Drug Resist Updat
2004; 7: 321–324.
17. Chan TA, Hermeking H, Lengauer C, Kinzler KW, Vogelstein B. 14-3-3s is required to
prevent mitotic catastrophe after DNA damage. Nature 1999; 401: 616–620.
18. Tse AN, Schwartz GK. Potentiation of cytotoxicity of topoisomerase I poison by concurrent
and sequential treatment with the checkpoint inhibitor UCN-01 involves disparate
mechanisms resulting in either p53-independent clonogenic suppression or
p53-dependent mitotic catastrophe. Cancer Res 2004; 64: 6635–6644.
19. Heng HH. The genome-centric concept: resynthesis of evolutionary theory. Bioessays
2009; 31: 512–525.
20. Stevens JB, Abdallah BY, Regan SM, Liu G, Bremer SW, Ye CJ et al. Comparison of
mitotic cell death by chromosome fragmentation to premature chromosome condensation.
Mol Cytogenet 2010; 3: 20.
21. Massabuau JC. From low arterial- to low tissue-oxygenation strategy. An evolutionary
theory. Respir Physiol 2001; 128: 249–261.
22. Zhang K, Kaufman RJ. From endoplasmic-reticulum stress to the inﬂammatory response.
Nature 2008; 454: 455–462.
23. Taylor BF, McNeely SC, Miller HL, States JC. Arsenite-induced mitotic death involves
stress response and is independent of tubulin polymerization. Toxicol Appl Pharmacol
2008; 230: 235–246.
24. Shen K, Wang Y, Brooks S, Raz A, Wang YA. ATM is activated by mitotic stress and
suppresses centrosome ampliﬁcation in primary but not in tumor cells. J Cell Biochem
2006; 99: 1267–1274.
System stresses lead to chromosome fragmentation
JB Stevens et al
8
Cell Death and Disease25. LangeBMH,BachiA,WilmM,Gonzalez C.Hsp90isa corecentrosomal componentandis
requiredatdifferentstagesofthecentrosomecycleinDrosophila andvertebrates.EMBOJ
2000; 19: 1252–1262.
26. Janssen A, Kops GJPL, Medema RH. Elevating the frequency of chromosome
mis-segregation as a strategy to kill tumor cells. Proc Natl Acad Sci USA 2009; 106:
19108–19113.
27. Korolchuk VI, Menzies FM, Rubinsztein DC. Mechanisms of cross-talk between
the ubiquitin–proteasome and autophagy–lysosome systems. FEBS Lett 2010; 584:
1393–1398.
28. Brown EJ, Baltimore D. ATR disruption leads to chromosomal fragmentation and early
embryonic lethality. Genes Dev 2000; 14: 397–402.
29. Fukasawa K, Wiener F, VandeWoude GF, Mai SB. Genomic instability and apoptosis are
frequent in p53 deﬁcient young mice. Oncogene 1997; 15: 1295–1302.
30. Hu ¨bnerB,StrickfadenH,Mu ¨llerS,CremerM,CremerT.Chromosomeshattering:amitotic
catastrophe due to chromosome condensation failure. Eur Biophys J 2009; 38: 729–747.
31. Taylor BF, McNeely SC, Miller HL, Lehmann GM, McCabe Jr MJ, States JC. p53
suppression of arsenite-induced mitotic catastrophe is mediated by p21CIP1/WAF1.
J Pharmacol Exp Ther 2006; 318: 142–151.
32. GodinhoS,KwonM,PellmanD.Centrosomesandcancer:howcancercellsdividewithtoo
many centrosomes. Cancer Metastasis Rev 2009; 28: 85–98.
33. Xu H, Ju D, Jarois T, Xie Y. Diminished feedback regulationof proteasome expression and
resistance to proteasome inhibitors in breast cancer cells. Breast Cancer Res Treat 2008;
107: 267–274.
34. Kroemer G, El-Deiry WS, Golstein P, Peter ME, Vaux D, Vandenabeele P et al.
Classiﬁcation of cell death: recommendations of the Nomenclature Committee on Cell
Death. Cell Death Differ 2005; 12 (S2): 1463–1467.
35. Carmona-Gutierrez D, Eisenberg T, Bu ¨ttner S, Meisinger C, Kroemer G, Madeo F.
Apoptosis in yeast: triggers, pathways, subroutines. Cell Death Differ 2010; 17: 763–773.
36. Niikura Y, Ogi H, Kikuchi K, Kitagawa K. BUB3 that dissociates from BUB1
activates caspase-independent mitotic death (CIMD). Cell Death Differ 2010; 17:
1011–1024.
37. O’Sullivan-Coyne G, O’Sullivan GC, O’Donovan TR, Piwocka K, McKenna SL. Curcumin
induces apoptosis-independent death in oesophageal cancer cells. BrJ Cancer 2009;101:
1585–1595.
38. Heng HH, Liu G, Stevens JB, Bremer SW, Ye KJ, Abdallah BY etal. Decodingthe genome
beyond sequencing: the new phase of genomic research. Genomics 2011; doi:10.1016/
j.ygeno.2011.05.008 (in press).
39. Xu J, Zhou J-Y, Tainsky MA, Wu GS. Evidence that tumor necrosis factor-related
apoptosis-inducing ligand induction by 5-aza-20-deoxycytidine sensitizes human breast
cancer cells to adriamycin. Cancer Res 2007; 67: 1203–1211.
40. Schlegel R, Pardee AB. Caffeine-induced uncoupling of mitosis from the completion of
DNA replication in mammalian cells. Science 1986; 232: 1264–1266.
41. Nichols WW, Levan A. Measles associated chromosome breakage. Archiv fe `ur die
gesamte Virusforschung 1965; 16: 168–174.
Cell Death and Disease is an open-access journal
published by Nature Publishing Group. This work is
licensed under the Creative Commons Attribution-Noncommercial-No
DerivativeWorks3.0UnportedLicense. To view acopyof thislicense,
visit http://creativecommons.org/licenses/by-nc-nd/3.0/
Supplementary Information accompanies the paper on Cell Death and Disease website (http://www.nature.com/cddis)
System stresses lead to chromosome fragmentation
JB Stevens et al
9
Cell Death and Disease